BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35126729)

  • 1. Investigation of miRNA expression profiles using cohort samples reveals potential early detectability of colorectal cancers by serum miR-26a-5p before clinical diagnosis.
    Hishida A; Yamada H; Ando Y; Okugawa Y; Shiozawa M; Miyagi Y; Daigo Y; Toiyama Y; Shirai Y; Tanaka K; Kubo Y; Okada R; Nagayoshi M; Tamura T; Mori A; Kondo T; Hamajima N; Takeuchi K; Wakai K
    Oncol Lett; 2022 Mar; 23(3):87. PubMed ID: 35126729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-627-5p and miR-199a-5p are promising diagnostic biomarkers of colorectal neoplasia.
    Zhao DY; Zhou L; Yin TF; Zhou YC; Zhou GY; Wang QQ; Yao SK
    World J Clin Cases; 2022 Jun; 10(16):5165-5184. PubMed ID: 35812667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas.
    Ardila HJ; Sanabria-Salas MC; Meneses X; Rios R; Huertas-Salgado A; Serrano ML
    Mol Clin Oncol; 2019 Aug; 11(2):201-207. PubMed ID: 31316774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer.
    Silva CMS; Barros-Filho MC; Wong DVT; Mello JBH; Nobre LMS; Wanderley CWS; Lucetti LT; Muniz HA; Paiva IKD; Kuasne H; Ferreira DPP; Cunha MPSS; Hirth CG; Silva PGB; Sant'Ana RO; Souza MHLP; Quetz JS; Rogatto SR; Lima-Junior RCP
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
    Yong FL; Law CW; Wang CW
    BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of A 6-Mirna Signature in Serum from Colorectal Cancer Screening Participants as Non-Invasive Biomarkers for Advanced Adenoma and Colorectal Cancer Detection.
    Marcuello M; Duran-Sanchon S; Moreno L; Lozano JJ; Bujanda L; Castells A; Gironella M
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a circulating microRNA signature for colorectal cancer detection.
    Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
    PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter Study.
    Pardini B; Ferrero G; Tarallo S; Gallo G; Francavilla A; Licheri N; Trompetto M; Clerico G; Senore C; Peyre S; Vymetalkova V; Vodickova L; Liska V; Vycital O; Levy M; Macinga P; Hucl T; Budinska E; Vodicka P; Cordero F; Naccarati A
    Gastroenterology; 2023 Sep; 165(3):582-599.e8. PubMed ID: 37263306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 5-serum miRNA panel for the early detection of colorectal cancer.
    Guo S; Zhang J; Wang B; Zhang B; Wang X; Huang L; Liu H; Jia B
    Onco Targets Ther; 2018; 11():2603-2614. PubMed ID: 29780253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
    Ghanbari R; Rezasoltani S; Hashemi J; Mohamadkhani A; Tahmasebifar A; Arefian E; Mobarra N; Asadi J; Nazemalhosseini Mojarad E; Yazdani Y; Knuutila S; Malekzadeh R
    Arch Iran Med; 2017 Feb; 20(2):92-95. PubMed ID: 28193082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
    Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
    Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
    Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
    Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
    Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer.
    Ding B; Yao M; Fan W; Lou W
    Aging (Albany NY); 2020 Mar; 12(6):5259-5279. PubMed ID: 32221048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer.
    Shi YJ; Fang YX; Tian TG; Chen WP; Sun Q; Guo FQ; Gong PQ; Li CM; Wang H; Hu ZQ; Li XX
    J Transl Med; 2023 Jun; 21(1):421. PubMed ID: 37386465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.